Project Grant R00DA057994
Award Date 7/1/26
Completion Date 6/30/29
Dollars Obligated $249K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Amherst, MA 01003, USA
Similar Awards
- The National Institute on Drug Abuse awarded Cambridge Health Alliance $776,604 on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to examine the impact of recreational cannabis legalization on cannabis, nicotine, and alcohol use among adolescents and young adults with mental illness. The research employs a convergent parallel mixed-methods design across two aims. Aim 1A analyzes National Survey on Drug Use and Health data from 2010–2025 to assess prevalence,...
- The National Institute on Drug Abuse awarded $121,500 to the University of Kansas Center For Research Inc. on December 1, 2025, under the Drug Use and Addiction Research Programs (CFDA 93.279). The research investigates contextual factors influencing cannabis use and behavioral economic demand in naturalistic environments. The project employs ecological momentary assessment and behavioral economic purchase tasks to extend laboratory-based research into real-world settings. The study will conduct...
- The National Institute on Drug Abuse awarded Boston University (Trustees of Boston University, doing business as Boston University Medical Campus) $732,747 on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to quantify the health effects of cannabis use and cannabis use disorder on geriatric syndromes and HIV outcomes through causal effects analysis in the Veterans Aging Cohort Study and the Mt. Sinai HIV Cohort. The project runs through March 31, 2031, with place...
- The National Institute on Drug Abuse awarded the Research Foundation For Mental Hygiene, Inc. (operating through its New York State Psychiatric Institute division) $195,804 on August 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds a five-year research project examining how cannabis influences nicotine use among young and emerging adults (ages 18–35) who use electronic nicotine delivery systems. The study integrates human laboratory methods with...
- The National Institute on Drug Abuse awarded $1.403928 million to the Regents of the University of Michigan on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to develop and test a remote behavioral economics-based intervention for cannabis use disorder delivered via synchronous videoconferencing. The research addresses the gap between prevalence of cannabis use disorder and treatment access: approximately 22 percent of cannabis users develop the condition, yet...
- The National Institute on Drug Abuse awarded Boston Medical Center Corporation $870,407 on September 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to support research on pre-release Medicaid effects on youth experiences related to substances (PRIME Years). The project addresses barriers to behavioral health service access for youth ages 16–25 following incarceration, a population with 36–84% prevalence of substance use history. The research examines Medicaid...
- This $668,110 Project Grant awarded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279) will fund the development and acceptability testing of a technology-based intervention to reduce cannabis misuse among college students. The project aims to refine an existing intervention that provides information on cannabis products, marketing, laws, and risks to increase young adults' cannabis literacy. The research will involve focus groups with...
- The National Institute on Drug Abuse awarded the University of Vermont $387,291 on March 1, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to conduct longitudinal research delineating developmental windows of vulnerability for cannabis exposure and assessing causal relationships between cannabis use, neurodevelopment, and behavior. The award funds analysis of three large multimodal neuroimaging datasets spanning preadolescence to late adulthood: ABCD (11,880 participants,...
- The National Institute on Drug Abuse, a component of the Department of Health and Human Services, awarded Trustees of Boston College $372,936 on June 15, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279) to evaluate the effects of recreational cannabis policies on prenatal cannabis use and maternal and child health outcomes. The project will conduct a novel data linkage study using Maine's natural experiment of staggered recreational cannabis legalization and retail sales...
- The National Institute on Drug Abuse awarded the University of California, San Diego $1,468,376 under the Drug Use and Addiction Research Programs (CFDA 93.279) on July 15, 2026, to conduct a prospective study characterizing sex-specific cannabinoid and endocannabinoid biomarkers as predictors of neuropsychological, behavioral, and withdrawal outcomes during cannabis abstinence in emerging adults. The research will recruit 220 participants aged 18–25 (balanced by sex, 64 percent with heavy...